Co-Authors
This is a "connection" page, showing publications co-authored by Tom Luedde and Ortwin Adams.
Connection Strength
0.298
-
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur. 2021 Sep; 8:100164.
Score: 0.239
-
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure. Front Immunol. 2021; 12:645989.
Score: 0.059